Table:
begin	end	state
1	18	non-cytoplasmic
19	47	transmembrane
48	58	cytoplasmic
59	82	transmembrane
83	109	non-cytoplasmic
110	135	transmembrane
136	142	cytoplasmic
143	161	transmembrane
162	166	non-cytoplasmic
167	185	transmembrane
186	194	cytoplasmic
195	215	transmembrane
216	261	non-cytoplasmic
262	283	transmembrane
284	320	cytoplasmic
321	347	transmembrane
348	358	non-cytoplasmic
359	382	transmembrane
383	393	cytoplasmic
394	411	transmembrane
412	437	non-cytoplasmic
438	453	transmembrane
454	471	non-cytoplasmic
472	493	transmembrane
494	506	cytoplasmic

Input:
>WP_086509281.1 NCBI__GCF_002151265.1:WP_086509281.1
MIDAFLVALNGVIEPYTLLLMAIGALAGIVSAAIPGFTITMAIVLTLPLTFAMPPLQGIA
VMLSVYVGGLSGGLFSAALLGIPGTPSSVATTFDAFPMARSGLPGKALALGLWSSFFGSL
ISIVVLILAAPPLALLAVKLGPWEYFALIVFALTVIASLVGDSLLRGLIAGLVGIGLATV
GPDPLMGRERFTFGYEMLSAGIPFLVVLIGMYAVSQLLSELETSPKQQAQGSTSLISGDM
RPHNLETLKAIVLRPVNVIRSSLIGVFIGAVPGAGSSISNLLAYDQAKRSSSHPENFGKG
EPQGVIASESGNSSTAGGGLIPLIALGIPGSAVDAVLMAAIMVHGISIGPRLILDNPELV
YGMFLSMAVASVLMLCIGLLLMRAFLNLLNVPKYFIVPVVLSCCVIGAFTLNNRITDLYL
LAGVGVVGYLFKKLDYPLAPLVLGVVLGPIAETNLRRAFQTSTDWTLFFTRPISAALLAL
AVASIVYSIVAYLRRSRPSSIPDSTT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server